Merck withdrew Vioxx due to increased stroke and heart attack risks, prompting global concern.
The European Medicines Agency and FDA are reviewing similar drugs.
Vioxx's withdrawal led to lawsuits in Canada and worldwide.
Merck faces financial losses and legal battles.
The impact on earnings is significant.
Vioxx's dangers were known before its recall, raising questions about Merck's transparency.
Legal experts predict a surge in lawsuits.
Studies suggest risks with similar drugs.
Lawyers are cautious about new cases.
The Vioxx litigation landscape is evolving, with potential for federal consolidation.
The focus is on identifying strong cases for settlement.
